{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:15:04Z","timestamp":1788952504455,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T00:00:00Z","timestamp":1640476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017720","name":"Kunming Science and Technology Bureau","doi-asserted-by":"publisher","award":["2019\u20131-N-25318000002027"],"award-info":[{"award-number":["2019\u20131-N-25318000002027"]}],"id":[{"id":"10.13039\/100017720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81360245"],"award-info":[{"award-number":["81360245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660477"],"award-info":[{"award-number":["81660477"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960499"],"award-info":[{"award-number":["81960499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2017IB020"],"award-info":[{"award-number":["2017IB020"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202001AY070001\u2013168"],"award-info":[{"award-number":["202001AY070001\u2013168"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.tranon.2021.101331","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T05:38:59Z","timestamp":1640842739000},"page":"101331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1\/caspase-3 axis"],"prefix":"10.1016","volume":"16","author":[{"given":"Zhuying","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2021.101331_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2021.101331_bib0002","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc1429","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"Wistuba","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2021.101331_bib0003","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tranon.2021.101331_bib0004","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2021.101331_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/cco.2019.08.13","article-title":"Gallbladder cancer: epidemiology and genetic risk associations","volume":"8","author":"Schmidt","year":"2019","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101331_bib0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-319-34244-3_6","article-title":"Gall bladder cancer","volume":"168","author":"Ertel","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.tranon.2021.101331_bib0007","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/ajg.2016.345","article-title":"Gallstones and the risk of gallbladder cancer mortality: a cohort study","volume":"111","author":"Ryu","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tranon.2021.101331_bib0008","first-page":"349","article-title":"Epidemiology and molecular pathology of gallbladder cancer","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2021.101331_bib0009","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/hep.31537","article-title":"Gallstones, body mass index, C-reactive protein, and gallbladder cancer: mendelian randomization analysis of chilean and european genotype data","volume":"73","author":"Barahona Ponce","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2021.101331_bib0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/cancers13030547","article-title":"Validation of the 8th edition American joint commission on cancer (AJCC) gallbladder cancer staging system: prognostic discrimination and identification of key predictive factors","volume":"13","author":"Giannis","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2021.101331_bib0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21037\/cco.2019.08.14","article-title":"Systemic therapy for gallbladder cancer","volume":"8","author":"Javle","year":"2019","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101331_bib0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cam4.2679","article-title":"Treatment of advanced gallbladder cancer: a SEER-based study","volume":"9","author":"Mao","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2021.101331_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0000000000000402","article-title":"The incidence rates and survival of gallbladder cancer in the USA","volume":"28","author":"Jaruvongvanich","year":"2019","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.tranon.2021.101331_bib0014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.gtc.2010.02.011","article-title":"Epidemiology of gallbladder cancer","volume":"39","author":"Eslick","year":"2010","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.tranon.2021.101331_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/bjs.11035","article-title":"Systematic review of management of incidental gallbladder cancer after cholecystectomy","volume":"106","author":"Soreide","year":"2019","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.tranon.2021.101331_bib0016","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.suc.2018.12.008","article-title":"Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies","volume":"99","author":"Hickman","year":"2019","journal-title":"Surg. Clin. N. Am."},{"key":"10.1016\/j.tranon.2021.101331_bib0017","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2021.101331_bib0018","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","article-title":"Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer","volume":"29","author":"Wang","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101331_bib0019","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2217\/fon-2020-0247","article-title":"NUC-1031\/cisplatin versus gemcitabine\/cisplatin in untreated locally advanced\/metastatic biliary tract cancer (NuTide:121)","volume":"16","author":"McNamara","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.tranon.2021.101331_bib0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00280-017-3353-2","article-title":"Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients","volume":"80","author":"Kim","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tranon.2021.101331_bib0021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11912-018-0664-3","article-title":"Updates on gallbladder cancer management","volume":"20","author":"Zaidi","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.tranon.2021.101331_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/cco.2019.07.05","article-title":"Systemic therapy of gallbladder cancer: review of first line, maintenance, neoadjuvant and second line therapy specific to gallbladder cancer","volume":"8","author":"Azizi","year":"2019","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101331_bib0023","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12885-020-6610-4","volume":"20","author":"Goetze","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2021.101331_bib0024","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejca.2019.10.004","article-title":"Modified gemcitabine and oxaliplatin or gemcitabine\u00a0+\u00a0cisplatin in unresectable gallbladder cancer: results of a phase III randomised controlled trial","volume":"123","author":"Sharma","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tranon.2021.101331_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12885-018-5211-y","article-title":"Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin","volume":"19","author":"You","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2021.101331_bib0026","doi-asserted-by":"crossref","first-page":"e2803","DOI":"10.1038\/cddis.2017.210","article-title":"Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer","volume":"8","author":"Xiao","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2021.101331_bib0027","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2021.101331_bib0028","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2021.101331_bib0029","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/0008-5472.CAN-03-3443","article-title":"GW112, a novel antiapoptotic protein that promotes tumor growth","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2021.101331_bib0030","doi-asserted-by":"crossref","first-page":"C494","DOI":"10.1152\/ajpcell.00336.2017","article-title":"Olfactomedin 4 contributes to hydrogen peroxide-induced NADPH oxidase activation and apoptosis in mouse neutrophils","volume":"315","author":"Liu","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tranon.2021.101331_bib0031","doi-asserted-by":"crossref","first-page":"11056","DOI":"10.1073\/pnas.1001269107","article-title":"Olfactomedin 4 down-regulates innate immunity against helicobacter pylori infection","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tranon.2021.101331_bib0032","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3748\/wjg.v24.i17.1881","article-title":"Olfactomedin-4 in digestive diseases: a mini-review","volume":"24","author":"Wang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2021.101331_bib0033","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10555-016-9624-2","article-title":"Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer","volume":"35","author":"Liu","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.tranon.2021.101331_bib0034","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00432-011-1042-9","article-title":"OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer","volume":"137","author":"Luo","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101331_bib0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1423-0127-19-38","article-title":"Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells","volume":"19","author":"Liu","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tranon.2021.101331_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152940","article-title":"Clinicopathological significance of olfactomedin-4 in extrahepatic bile duct carcinoma","volume":"216","author":"Jun","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.tranon.2021.101331_bib0037","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00428-015-1793-9","article-title":"Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric tumorigenesis and of prognostic significance in advanced gastric cancer","volume":"467","author":"Jang","year":"2015","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"10.1016\/j.tranon.2021.101331_bib0038","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/ibd\/izab025","article-title":"Overexpression of cancer-associated stem cell gene OLFM4 in the colonic epithelium of patients with primary sclerosing cholangitis","volume":"27","author":"Neyazi","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tranon.2021.101331_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28144","article-title":"Blocking OLFM4\/HIF-1\u03b1 axis alleviates hypoxia-induced invasion, epithelial-mesenchymal transition, and chemotherapy resistance in non-small-cell lung cancer","author":"Gao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tranon.2021.101331_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226707","article-title":"High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer","volume":"15","author":"Ohkuma","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tranon.2021.101331_bib0041","first-page":"25","article-title":"A transcriptome profile in gallbladder cancer based on annotation analysis of microarray studies","volume":"23","author":"Ge","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tranon.2021.101331_bib0042","first-page":"595","article-title":"[Genetic alterations in preneoplastic and neoplastic injuries of the gallbladder]","volume":"138","author":"Castillo","year":"2010","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.tranon.2021.101331_bib0043","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/1878-0261.12766","article-title":"Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia","volume":"14","author":"Rosa","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.tranon.2021.101331_bib0044","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.yexcr.2008.01.028","article-title":"Regulation of apoptotic and growth inhibitory activities of C\/EBPalpha in different cell lines","volume":"314","author":"Wang","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tranon.2021.101331_bib0045","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s11033-010-0037-y","article-title":"Inhibition of ADP-ribosylation factor-like 6 interacting protein 1 suppresses proliferation and reduces tumor cell invasion in CaSki human cervical cancer cells","volume":"37","author":"Guo","year":"2010","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tranon.2021.101331_bib0046","first-page":"508","article-title":"ARMER, apoptotic regulator in the membrane of the endoplasmic reticulum, a novel inhibitor of apoptosis","volume":"1","author":"Lui","year":"2003","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.tranon.2021.101331_bib0047","first-page":"1449","article-title":"ARL6IP1 mediates cisplatin-induced apoptosis in CaSki cervical cancer cells","volume":"23","author":"Guo","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2021.101331_bib0048","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12014-017-9143-3","article-title":"OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages","volume":"14","author":"Quesada-Calvo","year":"2017","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.tranon.2021.101331_bib0049","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800446","article-title":"OLFM4 expression in ductal carcinoma in situ and in invasive breast cancer cohorts by a SWATH-based proteomic approach","volume":"19","author":"Valo","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.tranon.2021.101331_bib0050","doi-asserted-by":"crossref","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","article-title":"Gallbladder carcinoma: prognostic factors and therapeutic options","volume":"21","author":"Goetze","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2021.101331_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17474124.2021.1853527","article-title":"Recent advances of immunotherapy for biliary tract cancer","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321003223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321003223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:21:53Z","timestamp":1761844913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523321003223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":51,"alternative-id":["S1936523321003223"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101331","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1\/caspase-3 axis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101331"}}